ROCKVILLIE, MD. and SUZHOU, China, Feb. 20, 2024 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company
Innovent Announces Primary Endpoint Met In The Phase 3 Clinical Trial (RESTORE-1) Of IBI311 (Anti-IGF-1R Antibody) In Treating Thyroid Eye Disease And menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
According to the American Thyroid Association, an estimated 20 million Americans have some form of thyroid disease and data from the American Cancer Society indicates that just over 44 thousand Americans will be diagnosed with thyroid cancer this year.